MedPath

Evaluation of Effectivity of Quadratus Lumborum Blocks With Adjuvant

Not Applicable
Completed
Conditions
Postoperative Pain Management
Nerve Block Duration
Analgesia
Postoperative Pain
Nerve Blocks
Cholecystectomy
Registration Number
NCT06028061
Lead Sponsor
Gaziosmanpasa Research and Education Hospital
Brief Summary

İn recent years abdominal wall blocks are widely used for to reduce intraoperative anesthetic recuirements and postoperative analgesia.Quadratus lumborum blocks are one of the abdominal wall blocks to used at laparoscopic cholecystectomy.Conventionally adjuvants used to improve and prolonged the effect of periferic nerve, spinal and abdominal blocks.İn this study investigators will evaluate the effectiveness of adjuvants at quatratus lumborum block at patient underwent laparoscopic cholecystectomy.

Detailed Description

Laparoscopic approach in cholecystectomy surgery is frequently preferred because of its advantages in systemic complications, morbidity, mortality and hospital stay. Pain is one of the important causes of late discharge after surgery. Laparoscopic cholecystectomy surgery requires a multimodal analgesia approach because of its multiple pain components.Regional analgesia techniques are effective in reducing the side effects such as intraoperative opioid use, postoperative pain and nausea and vomiting. Quadratus lumborum III block is a regional technique performed for multimodal analgesia.Adjuvants are known to improve the analgesic efficacy and prolonge the effect of the periferic and central nerve blocks.The aim of this study is to determine the effectiveness of adding adjuvant at quadratus lumborum block for patients who underwent laparoscopic cholecystectomy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
83
Inclusion Criteria

American Society of Anesthesiologists physical statusⅠ-II

Exclusion Criteria
  • Inclusion Criteria:
  • 18-65 years of age
  • American Society of Anesthesiologists physical statusⅠ-II

Exclusion Criteria:

  • local anesthetic allergy
  • Infection at the procedure site Body Mass Index >35 kg/m2 Anticoagulant use with bleeding disorder Chronic analgesia and opioid use with mental and psychiatric disorders Contraindications to regional anesthesia several lung and heart disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Total amount of opioid requirementswithin 24 hours after the surgery

The total tramadol use of the patients in 24 hours will be recorded.

rescue analgesiawithin 24 hours after the surgery

The rescue analgesia requirement and time of the need of the rescue analgesia requirement

Secondary Outcome Measures
NameTimeMethod
intraoperative remifentanil consumptionduring operation procedure]

The total remifentanil use to be used in the maintenance of 0.05-0.2 mcg/kg remifentanil will be recorded by titration according to the hemodynamic data of the intraoperative patients.

side effects such as nausea, vomiting and shoulder painwithin 24 hours after the surgery

The incidence of postoperative side effects such as nausea, vomiting and shoulder pain will be evaluated.

Visual Analogue Scale valuesat 1st, 4th,8th 12th and 24th hours after the surgery]

Visual Analogue Scale is a scale of 0-10 cm in length, expressed by non-standard verbal descriptors (no pain-unbearable pain..) indicating the limits of pain intensity on both sides, horizontally or vertically.

Trial Locations

Locations (1)

Gaziosmanpasa Research and Education Hospital

🇹🇷

İ̇stanbul, Marmara, Turkey

Gaziosmanpasa Research and Education Hospital
🇹🇷İ̇stanbul, Marmara, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.